PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

When germs attack: A lens into the molecular dance

2014-01-07
(Press-News.org) Contact information: Vanessa McMains
vmcmain1@jhmi.edu
410-502-9410
Johns Hopkins Medicine
When germs attack: A lens into the molecular dance

Researchers at Johns Hopkins have zoomed in on what is going on at the molecular level when the body recognizes and defends against an attack of pathogens, and the findings, they say, could influence how drugs are developed to treat autoimmune diseases.

The focus of the research is a pathogen "sensor" known as human IFN inducible protein-16 or IFI16, one of the body's key responders to viruses and bacteria, including herpes, HIV, listeria and salmonella. When IFI16 goes awry, it can prod the immune system to attack its own cells, triggering autoimmune disorders such as lupus and Sjögren syndrome (in which the glands that produce tears and saliva are destroyed). By figuring out how IFI16 operates, biophysicist Jungsan "Jay" Sohn, Ph.D., and his team say they have set the stage for finding ways to stop or limit the damage.

For the study, described online at the Proceedings of the National Academy of Science Early Edition in December, the Hopkins team used high-powered microscopy to show that these sensor proteins of the human immune system assemble into strands to signal infection. This strand-forming appears in other pathogen sensors, suggesting that this may be a common host defense mechanism.

"By understanding how IFI16 works at this fine molecular level, we may be able to boost this activity to build up immunity or taper down this activity to correct autoimmune disorders," says Sohn, an assistant professor of biophysics and biophysical chemistry.

Sohn and his research team first generated genetically engineered IFI16 from bacteria and exposed it to synthetic DNA sequences of varying lengths to see how the protein might react to "foreign," pathogenic DNA. They then observed the IFI16 and DNA interact via electron microscopy. What they saw was surprising.

The team expected that IFI16, like other pathogen sensors, would react to foreign DNA if it is long enough to accommodate just one IFI16 molecule. But IFI16 didn't react strongly until the synthetic DNA fragments exceeded 60 base pairs in length, which can accommodate about four IFI16 molecules. It was as if a light went on when the "invading" DNA reached 70 to 100 base pairs, Sohn says. "We call that switch-like behavior."

IFI16's preference for long DNA strands explains a longstanding mystery, according to Sohn. Researchers, he explains, have wondered how our bodies' immune systems mostly avoid "friendly fire," or being sent into overdrive and attacking themselves. The new experiments suggest that the length of DNA could be the key: Our DNA is packaged such that there are only short exposed fragments, and IFI16 won't activate in the presence of short DNA, but will in the presence of pathogenic DNA, which typically expose much longer strands.

"What we found suggests that the sensor uses the length of the naked DNA as a molecular ruler to distinguish self from non-self," Sohn says.

Subsequently, Sohn and his team investigated how a sensor like IFI16 was attracted to such long DNA. They found that IFI16 molecules line up along long pathogenic DNA strands to form chains, or filaments. The longer the naked DNA, the longer the chain. What's more, chains of IFI16 then line up and merge to create an even longer chain.

"The filaments emerge and elongate," Sohn says.

But that left the question of how IFI16 molecules were able to find each other and align. In another set of experiments, the team showed that IFI16 contains three protein parts — HinA, HinB and PYD — and when they broke up PYD, the chain failed to form.

What was surprising, he says, is that PYD doesn't bind directly to the pathogen's DNA. Rather, the Hin domains on IFI16 bind to the DNA, which makes the PYD domains gravitate toward one another. As a result, the PYDs glom together to form a powerful scaffold.

Sohn says his work suggests that the PYD-PYD interaction is very specific and a great potential drug target.

"It's really difficult to develop a drug that's targeting something that binds non-specifically. But PYD-PYD interaction is specific, and it only happens when it encounters DNA. It is what drives the stability of the complex. So if you can disintegrate that, it might alleviate autoimmune disorders," Sohn says. Conversely, developing drugs that bolster the scaffold could enhance immunity, he adds.



INFORMATION:

Additional authors on the paper include Seamus Morronea, Tao Wang, Leeza Constantoulakis, Richard Hooy and Michael Delannoy, all of The Johns Hopkins University.

This research was supported by Johns Hopkins School of Medicine startup funds.



ELSE PRESS RELEASES FROM THIS DATE:

Synthetic genetic clock checks the thermometer

2014-01-07
Synthetic genetic clock checks the thermometer Rice University leads study to counter effects of temperature on synthetic gene circuits HOUSTON – (Jan. 7, 2014) – Genetic systems run like clockwork, attuned to temperature, time of day and many other factors as they regulate ...

Dabrafenib in melanoma: Added benefit not proven

2014-01-07
Dabrafenib in melanoma: Added benefit not proven No differences could be shown for mortality, symptoms and quality of life / concerning side effects, data too uncertain Dabrafenib (trade name: Tafinlar) has been approved in Germany ...

Aflibercept in macular oedema: Added benefit not proven

2014-01-07
Aflibercept in macular oedema: Added benefit not proven Neither the new drug nor the comparator therapy was used in accordance with their approvals in the studies For the third time in one year, the German Institute for Quality ...

Increased risk of prostate cancer in African American men; implications for PSA screening

2014-01-07
Increased risk of prostate cancer in African American men; implications for PSA screening New Rochelle, NY, January 7, 2014—African American men have an increased risk of prostate cancer and are two times more likely than Caucasian American ...

Sugar-burning in the adult human brain is associated with continued growth, and remodeling

2014-01-07
Sugar-burning in the adult human brain is associated with continued growth, and remodeling Research published in the journal Cell Metabolism shows that hotspots of fuel consumption in the adult brain also show key characteristics of developing brain regions SEATTLE, ...

A CNIO research team discovers new regulators of the most prevalent liver disease

2014-01-07
A CNIO research team discovers new regulators of the most prevalent liver disease AP-1 proteins modulate fat accumulation in the liver, a disease termed fatty liver disease (FLD); the pharmacological manipulation of these proteins might help treating ...

Teriflunomide in multiple sclerosis: Added benefit not proven

2014-01-07
Teriflunomide in multiple sclerosis: Added benefit not proven Regarding side effects, there are both positive and negative effects in comparison with beta interferon 1a Teriflunomide (trade name: Aubagio) has been approved in Germany ...

NREL finds a new cellulose digestion mechanism by a fast-eating enzyme

2014-01-07
NREL finds a new cellulose digestion mechanism by a fast-eating enzyme CelA digests cellulose faster than enzymes from commercial preparations Researchers at the Energy Department's National Renewable Energy Laboratory (NREL) have discovered ...

MU researcher's study of African forest elephants helps guide research efforts in the US

2014-01-07
MU researcher's study of African forest elephants helps guide research efforts in the US Study finds that human occupation of an area may not contribute to population decline of an endangered species COLUMBIA, Mo. – Conservation of a protected or endangered ...

Story tips from the Department of Energy's Oak Ridge National Laboratory, January 2014

2014-01-07
Story tips from the Department of Energy's Oak Ridge National Laboratory, January 2014 To arrange for an interview with a researcher, please contact the Communications staff member identified at the end of each tip. For more information on ORNL and its research ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] When germs attack: A lens into the molecular dance